medicalxpress.com
Surgical approach has 'significant impact' on treatment of Crohn's disease - Medical Xpress
A surgical technique (mesentery removal) reported in an international randomized trial lowered early endoscopic recurrence after Crohn’s surgery. If validated more widely, it could reduce repeat operations and hospital readmissions for many patients.
Patients with Crohn’s disease facing intestinal surgery, surgeons and colorectal specialists, IBD clinicians, and researchers studying surgical management of IBD.
What To Know
New international randomized trial reported in Gastroenterology validates a surgical technique developed in Limerick that includes removal of the mesentery along with diseased intestine. The trial found lower endoscopic recurrence rates (about 46% → 23%) and reduced severity of relapse when the mesentery was removed.
The article frames this as supporting adoption of mesentery removal during Crohn’s surgery to reduce need for repeat operations and readmissions.
The study tested a surgical variation (removing the mesentery) versus conventional surgery in Crohn’s disease and reports substantially lower rates of early endoscopic recurrence and less severe relapse after the mesentery-removing procedure.
The article attributes the approach to work from University of Limerick/University Hospital Limerick and presents the trial as international validation. It does not provide full trial details in this news piece (protocol, exact patient numbers, follow-up duration, or adverse events).
If you are considering surgery for Crohn’s, this is promising research but not a direct treatment recommendation. Discuss with your surgeon whether mesenteric excision is offered locally, what the risks and benefits are in your case, and whether the published trial’s methods and follow-up apply to you.
Read the original Gastroenterology paper for complete methods, outcomes, and safety data before changing clinical decisions.
This news article summarizes trial results but omits detailed trial methodology, patient numbers, follow-up length, and safety/adverse-event data. The original Gastroenterology paper should be consulted to evaluate applicability and risks; this news piece does not by itself establish a change in standard care.
